Munro Lab
Current Studies
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease (Stress-AD)
This NIH-funded study aims to study individual differences in the response to stress and genes related to the stress response as predictors of cognitive functioning in individuals with mild cognitive impairment (MCI). A longitudinal portion will investigate the endocrine stress response and genetic factors as predictors of cognitive decline and blood-based biomarkers of neurodegeneration at a 2-year follow-up.
If you or someone you know is 60 years or older and would like to find out more about participating in this study, please call (410)-550-2036 to learn more.
Phase II Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
This Phase II drug trial is a 2-week, randomized, placebo-controlled, crossover study of the glucocorticoid receptor antagonist CORT108297 to treat stress-induced memory impairment in individuals who are at increased risk of developing Alzheimer’s disease. The study is funded by the Preservati Family Charitable Trust Foundation.
If you or someone you know is 55 years or older and want to find out about participation in this study, please call (410)-550-2036 to learn more.